Servier and Day One Biopharmaceuticals announce acquisition to expand Servier's rare oncology portfolio

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Servier-Day-One-Pharm

More Like This

PR Newswire associated0

Servier completes the acquisition of Day One Biopharmaceuticals

PR Newswire associated0

Servier delivers solid performance in 2024/25 and confirms its forecasts for 2030

Business Wire logo

BeOne Medicines Highlights Global Oncology Leadership at 44th Annual J.P. Morgan Healthcare Conference

PR Newswire associated0

Servier to Acquire Edgewise Therapeutics' Muscular Dystrophy Business

PR Newswire associated0

Servier's Voranigo® (vorasidenib) Receives Prix Galien Awards Across Multiple Regions

Business Wire logo

BeOne Medicines Showcases Groundbreaking Oncology Pipeline at R&D Day

BeOne Medicines' biologics manufacturing facility and clinical R&D center in Hopewell, NJ.

BeOne Medicines Launches Following Redomiciliation to Switzerland, Marking a New Chapter in Global Oncology

Business Wire logo

BeOne Medicines to Host Investor R&D Day Webcast on June 26, 2025